AGL Agilon Health: Koefisien utang jangka dawa marang modal

Logo korporat perusahaan Agilon Health Corp (AGL)

Agilon Health (AGL) provides platforms to optimize care for the elderly, leveraging an aging population and the implementation of AI to reduce costs. However, the business faces expansion from insurance behemoths establishing their own clinics and rising operating expenses. The price action, where the indicator stands at 0.08, confirms the company's struggle to maintain profitability and market share amid fierce competition.

Agilon Health (AGL): Utang jangka dawa marang modal saka 04.07.2022 nganti 28.10.2026
Barang utama Agilon Health

This ratio compares liabilities with a maturity of more than one year to the amount of equity, determining the degree of financial leverage and the company's dependence on external borrowings. In the context of Agilon Health (AGL), the long-term debt-to-equity ratio reflects the balance sheet structure's resilience to volatility in Medicare Advantage payments and fluctuations in medical expenses that impact final profitability.

Pesaing langsung

Rasio silihan jangka dawa marang modal Veeva Systems (VEEV)|Doximity Corp (DOCS) - Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal HQY (HealthEquity Building)|Waystar Holding Corp. - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang ekuitas corvel.com CRVL|PRVA (Privia Health) - Utang jangka dawa marang modal|HURN - Kewajiban jangka dawa marang modal|Utang jangka dawa marang modal Certara Corp|Omnicell Health (OMCL) - Rasio utang jangka dawa marang modal|GDRX (GoodRx Holdings, Inc.) - Utang jangka dawa marang modal|Utang jangka dawa marang modal schrodinger.com|PHR: Utang jangka dawa marang modal|Tanggungan utang jangka dawa marang ekuitas Omada Health, Inc. (OMDA)|Utang jangka dawa marang modal EVH|HealthStream Learning - Rasio tanggungan utang jangka dawa marang modal|DH - Utang jangka dawa marang ekuitas|CCSI: Utang jangka dawa marang ekuitas|Utang jangka dawa marang ekuitas ABSI|SY (So-Young International Inc) - Kewajiban jangka dawa marang modal|Utang jangka dawa marang ekuitas National Research (NRC)|Rasio utang jangka dawa marang modal USA Mobility (SPOK)|OptimizeRx Corporation (OPRX) - Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal trubridge.com (TBRG)|Utang jangka dawa marang modal Simulations Plus|Koefisien utang jangka dawa marang modal Sophia Genetics SOPH|HCAT (Health Catalyst, Inc) - Utang jangka dawa marang modal|CCLD - Kewajiban jangka dawa marang modal|RSSS: Utang jangka dawa marang modal|DLHC (DLH Holdings) - Utang jangka dawa marang modal|Utang jangka dawa marang ekuitas OneMedNet Corp|Utang jangka dawa marang ekuitas Scienture Holdings (SCNX)|Rasio utang jangka dawa marang ekuitas Healthcare Triangle Corp|Rasio silihan jangka dawa marang modal ispecimen.com (ISPC)|Utang jangka dawa marang modal Bullfrog AI|Koefisien utang jangka dawa marang modal scworx.com WORX|MSP Recovery - Utang jangka dawa marang modal|ICCT - Utang jangka dawa marang modal|Utang jangka dawa marang modal MEDS (TRxADE)|ORGS (Orgenesis Corporation) - Tanggungan utang jangka dawa marang ekuitas|Utang jangka dawa marang ekuitas R1 RCM, Inc.|Utang jangka dawa marang ekuitas sharecare.com|STRM (Streamline Health) - Utang jangka dawa marang modal|Rasio tanggungan utang jangka dawa marang modal Syra Health Corp SYRA|Rasio utang jangka dawa marang ekuitas Apollo Medical Holdings, Inc. (AMEH)|MODN - Rasio silihan jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas NextGen Healthcare (NXGN)